EUVIMEDEUVIMED entdecken
EvaluationsstudieOpen Access

Optimization and clinical evaluation of a 5.8S rRNA quantitative PCR assay for the diagnosis of talaromycosis

Dang Hoang Khanh, Lottie Brown iD, Phan Thi Ha My, Nguyen Thi Mai Thu, Emily Evans, Vo Trieu Ly, Nguyen Thanh Hiep, Ngo Thi Hoa, Thuy Le iD

Medical Mycology · 02.04.2025 · 63 (4)

DOI: 10.1093/mmy/myaf040 ↗

Kurz gefasst

Evaluationsstudie in der Zeitschrift Medical Mycology, online erschienen am 16.04.2025. Verfasst von Dang Hoang Khanh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Tropical Medicine Research Center for Talaromycosis in Vietnam, Center for Biomedical Research, Pham Ngoc Thach University of Medicine, Ho Chi Minh C…. Hauptthemen laut MEDLINE: Real-Time Polymerase Chain Reaction, Mycoses, Talaromyces, RNA, Ribosomal, 5.8S. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institute for Health Research, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Talaromyces marneffei is a dimorphic fungus endemic in Southeast Asia that causes the invasive fungal disease talaromycosis in immunocompromised individuals. Detection of T. marneffei nucleic acid in blood by PCR has demonstrated potential as a diagnostic tool for talaromycosis, but previously developed assays have limited sensitivity. This study described the optimization of a quantitative PCR (qPCR) assay for the diagnosis of talaromycosis. Our assay performance was maximized by testing different primers, methods of cell lysis and DNA extraction, whole blood vs. plasma, and methods of specimen treatment, using mean quantification cycle (Cq) values to compare performance. Our qPCR assay achieved the highest analytical sensitivity of 1 yeast cell per mL of whole blood, using primers targeting the 5.8S ribosomal DNA, cell lysis by bead beating, and DNA extraction by the MasterPure Yeast Purification Kit. There was no cross-reactivity observed with six Penicillium species and nine clinically related fungal isolates. In a case-control, diagnostic validation study of 138 cases of talaromycosis and 30 controls with other invasive fungal diseases and opportunistic infections, our 5.8S qPCR assay detected T. marneffei in 99.0% (101/102, 95% CI: 94.6%–99.9%) of blood culture-positive and 55.6% (20/37, 95% CI: 38.1%–72%) of blood culture-negative patients. Overall, our 5.8S qPCR assay had significantly higher sensitivity compared to conventional BACTEC blood culture, 87.7% (95% CI: 80.7%–92.5%) vs. 73.9% (95% CI: 65.6%–80.8%, P < .001), and the specificity was 96.7% (95% CI: 80.9%–99.8%). Our 5.8S qPCR assay has potential as a non-invasive and rapid rule-in test for talaromycosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Real-Time Polymerase Chain ReactionMycosesTalaromycesRNA, Ribosomal, 5.8SMolecular Diagnostic TechniquesHumansSensitivity and SpecificityDNA, FungalCase-Control StudiesMaleFemaleMiddle AgedAdultDNA PrimersAged

Stichwörter der Autor:innen

Talaromyces marneffeiPCRdiagnosismolecularpolymerase chain reactiontalaromycosis

Substanzen

RNA, Ribosomal, 5.8SDNA, FungalDNA Primers

Autor:innen und Institutionen

  • Tropical Medicine Research Center for Talaromycosis in Vietnam, Center for Biomedical Research, Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Vietnam.
  • Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
  • Institute of Infection and Immunity, City St George's University of London, School of Health & Medical Sciences, London, UK.
  • Clinical Infection Unit, St George's University Hospitals NHS Foundation Trust, London, UK.
  • Division of Infectious Diseases and International Health, Duke University School of Medicine, Durham, North Carolina, USA.
  • Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, USA.

ORCID-Profile: Lottie Brown, Thuy Le

Förderung

  • NIAID NIH HHS
  • National Institute for Health Research
  • National Institute of Allergy and Infectious Diseases
  • Dowager Countess Eleanor Peel Trust
  • Federation of European Microbiological Societies

Zitieren

APA

Khanh, D. H., Brown, L., My, P. T. H., Thu, N. T. M., Evans, E., Ly, V. T., Hiep, N. T., Hoa, N. T., & Le, T. (2025). Optimization and clinical evaluation of a 5.8S rRNA quantitative PCR assay for the diagnosis of talaromycosis. Medical Mycology, 63(4). https://doi.org/10.1093/mmy/myaf040

Vancouver

Khanh DH, Brown L, My PTH, Thu NTM, Evans E, Ly VT, et al. Optimization and clinical evaluation of a 5.8S rRNA quantitative PCR assay for the diagnosis of talaromycosis. Medical Mycology. 2025;63(4). doi:10.1093/mmy/myaf040

BibTeX
@article{Khanh2025,
  author = {Khanh, Dang Hoang and Brown, Lottie and My, Phan Thi Ha and Thu, Nguyen Thi Mai and Evans, Emily and Ly, Vo Trieu and Hiep, Nguyen Thanh and Hoa, Ngo Thi and Le, Thuy},
  title = {Optimization and clinical evaluation of a 5.8S rRNA quantitative PCR assay for the diagnosis of talaromycosis},
  journal = {Medical Mycology},
  year = {2025},
  volume = {63},
  number = {4},
  doi = {10.1093/mmy/myaf040}
}
Kostenlos starten →